We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Renal Cell Carcinoma

Journal Scan / Research · September 13, 2022

Role and Impact of PSMA PET/CT in Diagnosing and Managing Metastatic RCC

European Urology Open Science

 

Additional Info

Disclosure statements are available on the authors' profiles:

European Urology Open Science
Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma
Eur Urol Open Sci 2022 Aug 29;[EPub Ahead of Print], C Udovicich, J Callahan, M Bressel, et al

Further Reading